Project description
Profiling the messengers that cancer cells use to spread more than their word
In recent years, extracellular vesicles (EVs) have risen from relative obscurity to stardom. They are secreted by all cells and are now recognised as the carriers of biologically active molecules that travel to local or distant targets to mediate cell-cell communication. Cancer progression and metastasis is linked to EVs as these cells use EVs to export regulatory molecules like oncoproteins and oncopeptides. Further, EVs are found in bodily fluids, supporting their potential as blood-based or urine-based biomarkers as well as targets for cancer therapies. proEVLifeCycle is creating a dynamic team of researchers to enhance understanding of the lifecycle of EVs involved in prostate cancer to improve diagnosis and treatment of the most common cancer in men.
Objective
The prostate cancer Extracellular Vesicle LifeCycle (proEVLifeCycle) network is an innovative, multidisciplinary training
program focused on understanding the biology, biomarker potential and function of extracellular vesicles (EVs) to resolve
unmet clinical needs of prostate cancer (PCa). It is within this realm, that we will equip early stage researchers with the
knowledge, tools and a creative ethos to be independent scientists, leaders, and drivers of innovation. The lifecycle of EVs is
poorly understood and their potential as non-invasive biomarkers and therapy target/agents, a growing area of interest. This
research can perfectly be integrated with the high need for novel biomarkers and therapy targets for PCa. Any relief in the
burden of this disease will have major impact on the huge socio-economic problems for patients, families, caregivers and
society.
The ambitious scientific objectives are to unravel the mysteries of EV biogenesis, homing and uptake to explain how vesicles
operate in disease processes; their heterogeneity, their molecular complexity, the biological functions they drive, their local
and systemic dissemination and how these may be manipulated. Using state-of-the-art, network-wide shared model
systems, imaging and profiling tools, and systems biology, the program will enlighten the lifecycle of EVs and identify novel
EV biomarkers and PCa therapy targets to address the unmet clinical needs.
Our original network of 7 academic and 3 company beneficiaries and 11 partners, provides optimal scientific training, crosssectoral
awareness, entrepreneurship skills, communication in the modern age, extensive opportunities for mobility and
patient-facing experiences. We herein meet identified EU-skills gaps providing well-rounded and inventive experts primed for influential careers, contributing to patient well-being and economic prosperity within the EU.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine oncology prostate cancer
- social sciences economics and business business and management entrepreneurship
- natural sciences biological sciences cell biology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.1. - Fostering new skills by means of excellent initial training of researchers
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-ITN - Marie Skłodowska-Curie Innovative Training Networks (ITN)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-ITN-2019
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
3015 GD Rotterdam
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.